CD8 PET Tracer

OTHER2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Endometrial NeoplasmsMetastatic NeoplasmOvarian Neoplasms

Phase 1

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

RecruitingNCT07030712

Merck Sharp & Dohme LLCMetastatic Neoplasm

Start: 2025-07-23End: 2029-07-01Target: 67Updated: 2026-10-13

A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)

Not yet recruitingNCT07870278

Merck Sharp & Dohme LLCOvarian Neoplasms, Endometrial Neoplasms

Start: 2026-11-13End: 2031-07-07Target: 80Updated: 2026-10-13